WOODLINE PARTNERS LP – KalVista Pharmaceuticals, Inc. Transaction History
WOODLINE PARTNERS LP portfolio value:
$10.92M
portfolio value
WOODLINE PARTNERS LP quarter portfolio value change:
+47.46%
quarter
KalVista Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -30.73% | -334.00K shares | 229K | $14.51 | 752.88K |
| Q2 2022 | share | Increase | +118.68% | 589.86K shares | 3.36M | $9.84 | 1.08M |
| Q1 2022 | share | Increase | +258.24% | 358.27K shares | 5.49M | $14.74 | 497.01K |
| Q4 2021 | share | Increase | +7.26% | 9.38K shares | -421K | $13.58 | 138.73K |
| Q3 2021 | share | Increase | +27.18% | 27.64K shares | -180K | $17.45 | 129.35K |
| Q2 2021 | share | Decrease | -54.61% | -122.35K shares | -3.31M | $23.96 | 101.70K |
| Q1 2021 | share | Increase | 0.00% | 224.05K shares | 5.75M | $25.69 | 224.05K |